Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06296251 · ClinicalTrials.gov registry record · NA

Dietary Supplementation on Body Fat Composition

A NA study of Pre Diabetes and Dyslipidemias, sponsored by Brightseed.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06296251 is a NA study of Pre Diabetes and Dyslipidemias that is actively recruiting participants, run by Brightseed. The registered enrollment target is 150 participants, below the 727-participant average among 59 other Pre Diabetes trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06296251, a NA study of Pre Diabetes and Dyslipidemias, is actively recruiting participants, sponsored by Brightseed.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The purpose of the current study is to examine the effects of a dietary supplement containing plant derived phenolics at two different dose levels in otherwise generally healthy adults with risk factors (high BMI at dyslipidemia and/or pre-diabetes) for body fat composition. The primary hypothesis is that supplementation with plant derived phenolics will decrease body fat composition compared to placebo.

Interventions

  • OTHER Placebo treatment
  • DIETARY_SUPPLEMENT Plant derived phenolics

Study Locations (1)

Illinois

  • Biofortis Research - Addison

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-04-18
Est. Completion 2025-02-27
Phase NA

Sponsor

Brightseed

3 total trials

What the Registry Record Tells You About NCT06296251

The ClinicalTrials.gov registry entry for NCT06296251 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 727-participant average among 59 other Pre Diabetes trials with a reported enrollment target (79% lower). The listed sponsor is Brightseed, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pre Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo treatment is the first listed.

NCT06296251 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06296251 about?

NCT06296251 is a clinical study titled "Dietary Supplementation on Body Fat Composition". The purpose of the current study is to examine the effects of a dietary supplement containing plant derived phenolics at two different dose levels in otherwise generally healthy adults with risk factors (high BMI at dyslipidemia and/or pre-diabetes) for body fat composition. The primary hypothesis i...

What is the current status of trial NCT06296251?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-04-18. Estimated completion is 2025-02-27.

What conditions does trial NCT06296251 study?

This clinical trial studies the following conditions: Pre Diabetes, Dyslipidemias.

What interventions are being tested in trial NCT06296251?

The interventions under investigation include: Placebo treatment (OTHER), Plant derived phenolics (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06296251?

This trial is sponsored by Brightseed, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06296251 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pre Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.